David A. Gass, Partner

Insights

September 16, 2020 "The Modified Standards for Section 706.07(b)'s first action final rejections (FAFR)" 2020 IPO Virtual Annual Meeting – U.S. Patent Office Practice Committee Meeting David Gass
September 16, 2020 "MPEP Updates on First-Action Final Rejections" 2020 IPO Virtual Annual Meeting – Pharmaceutical & Biotechnology Issues Committee Meeting David Gass
June 2013 – Presentation 2013 BIO International Convention, Chicago, IL Panel speaker on the topic of IP protection for biomarker diagnostics David Gass
July 2012 – Presentation “Patent Protection for Antibody Inventions” Speaker, London, U.K. David Gass
2012 – Presentation 2012 BIO International Convention, Boston, MA Panel speaker on the topic of IP protection for biomarker diagnostics David Gass
2011 – Presentation 2011 BIO International Convention, Washington D.C. Panel moderator and speaker on the topic of IP protection for biomarker diagnostics. David Gass
May 2011 “Impact of Recent IP Case law on Biomarkers and Personalized Medicine” Journal of Commercial Biotechnology David Gass
2011 – Presentation 2011 Biotechnology and Health-Related Issues Intellectual Property Law Symposium, John Marshall Law School, Chicago Panelist, provided analysis of IP law and strategies for diagnostic and biomarker-based intellectual property in light of recent legal developments, including high profile Supreme Court and Federal Circuit cases such as Bilski, Myriad (AMP v. USPTO), Mayo v. Prometheus, and Classen. David Gass
June 2010 2010 BIO International Convention, Chicago, IL Panel moderator and speaker on the topic of IP protection for biomarker diagnostics. David Gass
Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.